Bilal Arif
CIK 1959750 · Chief Operations Officer · last filed 2026-06-11
Bilal Arif is a Chief Operations Officer who has filed 22 SEC Form 4 insider transactions across 2 companies since 2023. The most recent filing, for KALV, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $558.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$558.4K
2
22
-$2.18M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) Delisted | Chief Operations Officer | — | $27.00 | — | $0 | 3 | 2026-06-11 |
| SRPT | Chief Tech Ops Officer | 32,500 | $17.18 | $558.4K | -$2.18M | 16 | 2025-08-06 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Disp (D) | — | $0 | EDGAR |
| 2026-01-21 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-10-08 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-08-06 | SRPT | Grant (A) | — | $0 | EDGAR |
| 2025-03-11 | SRPT | Mixed | +7,753 | -$52.4K | EDGAR |
| 2025-03-10 | SRPT | Mixed | +8,465 | -$936.9K | EDGAR |
| 2025-03-06 | SRPT | Tax (F) | −514 | -$52.1K | EDGAR |
| 2025-03-04 | SRPT | Tax (F) | −719 | -$74.6K | EDGAR |
| 2025-02-13 | SRPT | Grant (A) | — | $0 | EDGAR |
| 2024-06-25 | SRPT | Notice (144) | −3,898 | -$638.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.